Carmel Hospital

Haifa 3436212

2 studies enrolling now · 8 studies all time

What they study most

Amyloidosis, Atherosclerotic Cardiovascular Disease (ASCVD), Breast Neoplasms, Circadian Rhythm Disorders, Diabetes Mellitus, Type 1, Elevated Lp(a), Insomnia, Insufficient Sleep Syndrome, Metabolic Dysfunction-Associated Steatotic Liver Disease, Nonalcoholic Steatohepatitis, Obesity, Sleep Apnea Syndromes

Studies at this site

• A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2) — Recruiting now
• A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults — Recruiting now
• A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes) — Recruiting now
• A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a) — Running, not enrolling
• A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer — Running, not enrolling
• A Study to Evaluate the Efficacy and Safety of Daratumumab in Combination With Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) Compared to CyBorD Alone in Newly Diagnosed Systemic Amyloid Light-chain (AL) Amyloidosis — Completed
• A Study of Tirzepatide (LY3298176) in Participants With Nonalcoholic Steatohepatitis (NASH) — Completed
• Evaluation of the Reliability and Validity of a Diagnostic Sleep Disorders Questionnaire — Completed